JP­M's M&A Mon­day fren­zy; Ozem­pic se­lect­ed for IRA ne­go­ti­a­tions; Pfiz­er says it's back on track; and more

Wel­come back to the new and im­proved End­points Week­ly! This week we’ll be re­cap­ping the JP Mor­gan Health­care Con­fer­ence, IRA price ne­go­ti­a­tions, Pfiz­er’s plans to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER